晚期色素性青光眼中房角镜辅助经腔内小梁切开术的疗效
本先导性随机对照试验比较了房角镜辅助经腔内小梁切开术(GATT)与小梁切除术在晚期色素性青光眼(PG)患者中12个月的结果。GATT组(n=10)术前平均眼压28.2±11.2 mm Hg、降眼压药物4±0.8种,术后12个月降至11.8±2.5 mm Hg和0.7种;小梁切除术组(n=12)由27.3±5.5 mm Hg和3.6±0.7种降至11.5±2.2 mm Hg和0.5±0.9种。全部患眼(100%)达到条件性成功;绝对成功率按标准A为GATT组60%、小梁切除术组67.7%,按标准B为GATT组50%、小梁切除术组58.3%。小梁切除术组2眼发生低眼压,GATT组无威胁视力的并发症(p=0.4)。结论认为,单独GATT在晚期PG患者中显著降低眼压和降眼压药物数量。
要点
- GATT组12个月眼压由28.2±11.2 mm Hg降至11.8±2.5 mm Hg,降眼压药物由4±0.8种降至0.7种。
- 小梁切除术组12个月眼压由27.3±5.5 mm Hg降至11.5±2.2 mm Hg,降眼压药物由3.6±0.7种降至0.5±0.9种。
- 全部患眼(100%)达到条件性成功;绝对成功率按标准A为GATT组60% vs 小梁切除术组67.7%,按标准B为GATT组50% vs 小梁切除术组58.3%。
核心结论
- 单独GATT在晚期PG患者中显示出眼压和降眼压药物数量的显著降低。
研究设计与样本
- 本先导性随机对照试验纳入晚期PG患者(平均偏差差于-12 dB),分别接受GATT或穹窿部基底小梁切除术。
- GATT组n=10,小梁切除术组n=12,比较12个月的结果。
主要发现
- GATT组术前平均眼压28.2±11.2 mm Hg、降眼压药物4±0.8种,术后12个月降至11.8±2.5 mm Hg和0.7种。
- 小梁切除术组术前平均眼压27.3±5.5 mm Hg、降眼压药物3.6±0.7种,术后12个月降至11.5±2.2 mm Hg和0.5±0.9种。
- 全部患眼(100%)达到条件性成功。
- 绝对成功率按标准A为GATT组60% vs 小梁切除术组67.7%,按标准B为GATT组50% vs 小梁切除术组58.3%。
- 小梁切除术组2眼发生低眼压,GATT组无威胁视力的并发症(p=0.4)。
关键数值与推荐
- 绝对成功(标准A)定义为术后眼压6至18 mm Hg,较治疗前值下降至少30%,且无需任何降眼压药物。
- 成功(标准B)按目标眼压定义:平均偏差在-12至-24 dB之间者上限为15 mm Hg,平均偏差差于-24 dB者上限为12 mm Hg或更低。
- 条件性成功为在相同或更少抗青光眼药物下达到相似的眼压标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) over a 12-month period with trabeculectomy in patients with advanced pigmentary glaucoma (PG). METHODS: This was a pilot randomised controlled trial of patients with advanced PG (mean deviation worse than -12 dB), undergoing either GATT or a fornix-based trabeculectomy. Absolute success (criterion A) was defined as a postoperative intraocular pressure (IOP) between 6 and 18 mm Hg, with a drop of at least 30% from the treated preoperative value without need of any IOP-lowering medication. Success (criterion B) was also defined as per the target IOP, with an upper limit of 15 mm Hg for eyes with mean deviation (MD) between -12 and -24 dB, and 12 mm Hg or lower for MD values worse than -24 dB. Qualified success was a similar IOP standard on the same or fewer antiglaucoma medications. RESULTS: For GATT (n=10), mean preoperative IOP and number of glaucoma medications were 28.2±11.2 mm Hg and 4±0.8 that reduced to 11.8±2.5 mm Hg and 0.7 at 12 months postoperatively, while in the trabeculectomy (n=12) group, they were 27.3±5.5 mm Hg and 3.6±0.7 that reduced to 11.5±2.2 mm Hg and 0.5±0.9, respectively. All eyes (100%) achieved qualified success. Absolute success was 60% and 67.7% by criterion A and 50% and 58.3% by criterion B for GATT and trabeculectomy, respectively. Two eyes in the trabeculectomy group developed hypotony while none of the GATT group had any sight-threatening complications (p=0.4). CONCLUSIONS: GATT alone demonstrated a significant reduction in IOP and number of glaucoma medications in patients with advanced PG.
引用
- Panigrahi A, Kumar A, Gupta S, et al. Outcomes of gonioscopy-assisted transluminal trabeculotomy in advanced pigmentary glaucoma. Br J Ophthalmol. 2025. PMID: 39317433. doi:10.1136/bjo-2024-325749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。